CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus Macaques

Induction of broadly neutralizing antibodies (bNAbs) is a major goal for HIV vaccine development. HIV envelope glycoprotein (Env)-specific bNAbs isolated from HIV-infected individuals exhibit substantial somatic hypermutation and correlate with T follicular helper (Tfh) responses. Using the VC10014...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology Vol. 12; p. 757811
Main Authors: Sarkar, Sanghita, Spencer, David A, Barnette, Philip, Pandey, Shilpi, Sutton, William F, Basu, Madhubanti, Burch, Reuben E, Cleveland, John D, Rosenberg, Alexander F, Rangel-Moreno, Javier, Keefer, Michael C, Hessell, Ann J, Haigwood, Nancy L, Kobie, James J
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 20-10-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Induction of broadly neutralizing antibodies (bNAbs) is a major goal for HIV vaccine development. HIV envelope glycoprotein (Env)-specific bNAbs isolated from HIV-infected individuals exhibit substantial somatic hypermutation and correlate with T follicular helper (Tfh) responses. Using the VC10014 DNA-protein co-immunization vaccine platform consisting of gp160 plasmids and gp140 trimeric proteins derived from an HIV-1 infected subject that developed bNAbs, we determined the characteristics of the Env-specific humoral response in vaccinated rhesus macaques in the context of CD4+ T cell depletion. Unexpectedly, both CD4+ depleted and non-depleted animals developed comparable Tier 1 and 2 heterologous HIV-1 neutralizing plasma antibody titers. There was no deficit in protection from SHIV challenge, no diminution of titers of HIV Env-specific cross-clade binding antibodies, antibody dependent cellular phagocytosis, or antibody-dependent complement deposition in the CD4+ depleted animals. These collective results suggest that in the presence of diminished CD4+ T cell help, HIV neutralizing antibodies were still generated, which may have implications for developing effective HIV vaccine strategies.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
This article was submitted to Vaccines and Molecular Therapeutics, a section of the journal Frontiers in Immunology
Edited by: Bryce Chackerian, University of New Mexico, United States
Reviewed by: Stephen Kent, The University of Melbourne, Australia; Jason T. Kimata, Baylor College of Medicine, United States; Cynthia Ann Derdeyn, Emory University, United States
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2021.757811